Ruxolitinib for tocilizumab-refractory severe COVID-19 infection.

Saved in:
Bibliographic Details
Title: Ruxolitinib for tocilizumab-refractory severe COVID-19 infection.
Authors: Innes AJ; Centre for Haematology, Department of Immunology & Inflammation, Imperial College London, London, UK.; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK., Cook LB; Centre for Haematology, Department of Immunology & Inflammation, Imperial College London, London, UK.; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK., Marks S; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK., Bataillard E; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK., Crossette-Thambiah C; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK., Sivasubramaniam G; Department of Respiratory Medicine, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK., Apperley J; Centre for Haematology, Department of Immunology & Inflammation, Imperial College London, London, UK.; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK., Milojkovic D; Centre for Haematology, Department of Immunology & Inflammation, Imperial College London, London, UK.; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
Source: British journal of haematology [Br J Haematol] 2020 Aug; Vol. 190 (4), pp. e198-e200. Date of Electronic Publication: 2020 Jul 26.
Publication Type: Clinical Trial; Letter
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32593183
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ruxolitinib for tocilizumab-refractory severe COVID-19 infection.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Innes+AJ%22">Innes AJ</searchLink>; Centre for Haematology, Department of Immunology & Inflammation, Imperial College London, London, UK.; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Cook+LB%22">Cook LB</searchLink>; Centre for Haematology, Department of Immunology & Inflammation, Imperial College London, London, UK.; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Marks+S%22">Marks S</searchLink>; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Bataillard+E%22">Bataillard E</searchLink>; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Crossette-Thambiah+C%22">Crossette-Thambiah C</searchLink>; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Sivasubramaniam+G%22">Sivasubramaniam G</searchLink>; Department of Respiratory Medicine, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Apperley+J%22">Apperley J</searchLink>; Centre for Haematology, Department of Immunology & Inflammation, Imperial College London, London, UK.; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Milojkovic+D%22">Milojkovic D</searchLink>; Centre for Haematology, Department of Immunology & Inflammation, Imperial College London, London, UK.; Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2020 Aug; Vol. 190 (4), pp. e198-e200. <i>Date of Electronic Publication: </i>2020 Jul 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32593183
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/bjh.16979
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e198
    Titles:
      – TitleFull: Ruxolitinib for tocilizumab-refractory severe COVID-19 infection.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Innes AJ
      – PersonEntity:
          Name:
            NameFull: Cook LB
      – PersonEntity:
          Name:
            NameFull: Marks S
      – PersonEntity:
          Name:
            NameFull: Bataillard E
      – PersonEntity:
          Name:
            NameFull: Crossette-Thambiah C
      – PersonEntity:
          Name:
            NameFull: Sivasubramaniam G
      – PersonEntity:
          Name:
            NameFull: Apperley J
      – PersonEntity:
          Name:
            NameFull: Milojkovic D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2020 Aug
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2141
          Numbering:
            – Type: volume
              Value: 190
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: British journal of haematology
              Type: main
ResultId 1